For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...

Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September. The drug has a novel mechanism of action ...

Schizophrenia causes symptoms that doctors classify as positive or negative. Positive symptoms of schizophrenia include hallucinations, delusions, and certain changes in thoughts or behaviors ...

Most individuals use medication during pregnancy. However, decision making on antenatal pharmacotherapy presents considerable ethical and scientific challenges. Amid a sociocultural paradigm ...

Schizophrenia is a serious mental disorder involving changes in perception, thoughts, and behaviors. It typically involves a disconnection from reality, in which a person experiences ...

Copyright 2024 The Associated Press. All Rights Reserved. This image provided by Bristol Myers Squibb in October 2024 shows the company’s drug Cobenfy, which the U ...

Individuals with high-dose prescription amphetamine use in the past month were almost 6 times more likely to have incident psychosis and mania, relative to non-use. High doses of prescription ...

Art therapy uses creative expression to help communicate the feelings, hallucinations, and experiences of those with schizophrenia. Art therapy can help people express emotions and thoughts that ...

The acquisition will include Aliada’s ALIA-1758, which is in development for Alzheimer’s disease. Credit: Art_Photo/Shutterstock. AbbVie has entered a definitive agreement to acquire all outstanding ...

Auditory verbal hallucinations are one of the hallmarks of psychosis, particularly in people with schizophrenia, which affects 24 million people globally. These voices often bully or abuse the ...